成都威斯克生物医药有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use 2023-06-09 11:59
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. 2023-05-18 21:23
Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB.1.5 and BA.5 by WestVac Biopharma 2023-02-20 12:43
COVID-19 Vaccine Developed by WestVac BioPharma Has High Titer Neutralizing Antibodies Against Omicron 2021-12-24 19:57
A China-developed COVID-19 vaccine is conducting clinical trial in Philippines 2021-10-14 12:58
1